ES2082390T3 - Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. - Google Patents

Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.

Info

Publication number
ES2082390T3
ES2082390T3 ES92310807T ES92310807T ES2082390T3 ES 2082390 T3 ES2082390 T3 ES 2082390T3 ES 92310807 T ES92310807 T ES 92310807T ES 92310807 T ES92310807 T ES 92310807T ES 2082390 T3 ES2082390 T3 ES 2082390T3
Authority
ES
Spain
Prior art keywords
gamma
linolenic acid
preparation
arteries
reoclusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92310807T
Other languages
English (en)
Inventor
David Frederick Horrobin
John Charles Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of ES2082390T3 publication Critical patent/ES2082390T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Control Of Turbines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Amplifiers (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Glass Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Semiconductor Lasers (AREA)
  • Drying Of Semiconductors (AREA)

Abstract

EL ACIDO GAMMA-LINOLENICO Y/O EL ACIDO DIHOMO-GAMMA-LINOLENICO SE UTILIZA EN LA PREPARACION DE UN MEDICAMENTO PARA INHIBIR LA REOCLUSION DE UNA ARTERIA DE LA CUAL SE ELIMINO UNA OCLUSION O CUALQUIER OTRO BLOQUEO O PARA IMPEDIR LA OCLUSION DE ARTERIAS PERIFERICAS O CORONARIAS. EL MEDICAMENTO PUEDE COMPRENDER TAMBIEN ACIDO EICOSAPENTAENOICO.
ES92310807T 1991-12-02 1992-11-26 Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. Expired - Lifetime ES2082390T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125602A GB9125602D0 (en) 1991-12-02 1991-12-02 Method of preventing reocclusion of arteries

Publications (1)

Publication Number Publication Date
ES2082390T3 true ES2082390T3 (es) 1996-03-16

Family

ID=10705559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92310807T Expired - Lifetime ES2082390T3 (es) 1991-12-02 1992-11-26 Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.

Country Status (17)

Country Link
US (2) US5378732A (es)
EP (2) EP0676197A3 (es)
JP (1) JPH05286854A (es)
KR (1) KR930012009A (es)
AT (1) ATE133334T1 (es)
AU (2) AU657009B2 (es)
CA (1) CA2084273A1 (es)
DE (1) DE69207885T2 (es)
DK (1) DK0551729T3 (es)
ES (1) ES2082390T3 (es)
GB (1) GB9125602D0 (es)
GR (1) GR3019270T3 (es)
HK (1) HK131096A (es)
NO (1) NO303047B1 (es)
NZ (1) NZ245343A (es)
TW (1) TW223589B (es)
ZA (1) ZA929316B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
WO2005108535A2 (en) * 2004-04-30 2005-11-17 Nutriscience Technology, Inc. Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
JP5345402B2 (ja) * 2007-01-17 2013-11-20 持田製薬株式会社 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240513A (en) * 1968-09-13 1971-07-28 Ono Pharmaceutical Co Poly-unsaturated fatty acid ester composition and its preparation
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids

Also Published As

Publication number Publication date
NO924637L (no) 1993-06-03
DK0551729T3 (da) 1996-02-12
US5378732A (en) 1995-01-03
US5859055A (en) 1999-01-12
GR3019270T3 (en) 1996-06-30
NO924637D0 (no) 1992-12-01
CA2084273A1 (en) 1993-06-03
AU657009B2 (en) 1995-02-23
ATE133334T1 (de) 1996-02-15
HK131096A (en) 1996-07-26
DE69207885D1 (de) 1996-03-07
DE69207885T2 (de) 1996-07-25
NZ245343A (en) 1997-06-24
TW223589B (es) 1994-05-11
EP0551729B1 (en) 1996-01-24
AU680725B2 (en) 1997-08-07
EP0676197A2 (en) 1995-10-11
EP0676197A3 (en) 1996-09-11
KR930012009A (ko) 1993-07-20
NO303047B1 (no) 1998-05-25
EP0551729A1 (en) 1993-07-21
AU2968792A (en) 1993-06-03
ZA929316B (en) 1993-09-09
GB9125602D0 (en) 1992-01-29
JPH05286854A (ja) 1993-11-02
AU1656395A (en) 1995-06-29

Similar Documents

Publication Publication Date Title
HK37694A (en) Fatty acids compositions
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
ES2045120T3 (es) Metodo para preparar un medicamento para el tratamiento o la prevencion de la perdida de memoria.
ES2107622T3 (es) Medicamento para el tratamiento de la distrofia vulvar o la sequedad vaginal.
FI863976A0 (fi) Terapeutisk komposition.
ATE120954T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
ATE22533T1 (de) Pharmazeutische zusammensetzung.
ES2073533T3 (es) Uso antivirico de composiciones que constan de acidos grasos esenciales e interferon.
ES2082390T3 (es) Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
EP0302481A3 (en) Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551729

Country of ref document: ES